Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | NLRP3 | Q96P20 | 12/20 | 0.58 |
| ▸ | PARP1 | P09874 | 2/20 | 0.54 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.51 |
| ▸ | SELE | P16581 | 1/20 | 0.51 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.51 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.51 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7241217 | 0.85 | KMT2A (0.59) | KMT2AMEN1NLRP3PARP1PARP10 | |
| SCHEMBL7245406 | 0.84 | NLRP3 (0.58) | KMT2AMEN1NLRP3 | |
| SCHEMBL4423340 | 0.82 | EPHX2 (0.71) | KMT2AMEN1NLRP3SELPSELE | |
| SCHEMBL26099719 | 0.82 | USP2 (0.68) | KMT2AMEN1NLRP3PARP1PARP10 | |
| SCHEMBL31306545 | 0.81 | ANO1 (0.69) | NLRP3 | |
| SCHEMBL21197987 | 0.81 | ANO1 (0.69) | NLRP3 | |
| SCHEMBL5102596 | 0.80 | MEN1 (0.64) | KMT2AMEN1NLRP3SELPSELE | |
| SCHEMBL29520161 | 0.79 | NLRP3 (0.75) | KMT2AMEN1NLRP3 | |
| SCHEMBL4423342 | 0.79 | NLRP3 (0.75) | KMT2AMEN1NLRP3 | |
| SCHEMBL18671651 | 0.79 | KMT2A (0.87) | KMT2AMEN1PARP1PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030083523-A1 | Amide derivatives | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-05-01 | — | — | US | disclosed |
| US-6444849-B1 | BACTERICIDES | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-09-03 | — | — | US | disclosed |
| EP-0887341-A1 | Amide derivatives | MITSUBISHI CHEMICAL CORPORATION (JP) | 1998-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030083523-A1 | Amide derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, CBR1 | KMT2A 1956/4885MEN1 2901/4885NLRP3 2976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.